Western Superconducting Technologies (688122) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
29 Oct, 2026Executive summary
9M revenue fell 2.87% YoY to RMB 3.874bn; attributable net profit declined 59.62% to RMB 262.3m.
Q3 attributable net loss was RMB 83.0m, while adjusted attributable net profit was RMB 45.7m; lower fair-value gains and weaker product margins weighed on results.
Financial highlights
Q3 revenue was RMB 1.263bn, down 0.28% YoY; 9M revenue was RMB 3.874bn, down 2.87%.
9M total profit was RMB 390.3m, down 52.76%; attributable net profit was RMB 262.3m, down 59.62%, and adjusted attributable net profit was RMB 201.5m, down 65.76%.
9M net profit was RMB 355.4m, versus RMB 737.2m a year earlier; basic and diluted EPS were RMB 0.40, versus RMB 1.00.
Key financial ratios and metrics
Weighted average ROE was -1.16% in Q3, down 2.67 percentage points YoY; 9M ROE was 3.66%, down 5.80 percentage points.
9M R&D spending was RMB 373.7m, up 43.82% YoY; R&D was 9.65% of revenue, up 3.14 percentage points.
Total assets at Sept. 30 were RMB 16.335bn, up 8.26% from year-end; parent equity was RMB 7.020bn, down 1.52%.
Latest events from Western Superconducting Technologies
- H1 2026 revenue and profit declined sharply on margin pressure, but R&D and strategic expansion continued.688122
H1 2026 - Net profit plunged 74% in Q1 2026 as sales prices and subsidies declined.688122
Q1 2026 - Revenue up 13.29% and net profit up 4.81%, led by superconducting and superalloy growth.688122
H2 2025 - Q3 profit dropped 59% on higher R&D costs, despite 4% revenue growth year-over-year.688122
Q3 2025 - H1 2025 revenue up 34.76%, net profit up 56.72%, with robust growth across all segments.688122
H1 2025 - Revenue and net profit rose sharply year-over-year, but operating cash flow dropped significantly.688122
Q1 2025 - Q3 net profit jumped 58% year-over-year on strong revenue and government subsidies.688122
Q3 2024 - H1 2024 net profit fell 17.24% as revenue declined and R&D investment surged.688122
H1 2024 - Double-digit revenue growth and higher net profit reflect strong market and operational gains.688122
H2 2024